Subscribe via RSS- NEWS ARCHIVES
-
2008
2007
2006
2005
2004
Pharma & Bio Ingredients
Lead defendant Wang Xun is accused of illegally purchasing the Tamiflu formula for $20,000 and then joining with others to pirate and sell the ersatz drug, Shanghai's Youth Daily and other newspapers said.
Shanghai's No. 2 Intermediate Court confirmed the trial began on Thursday, but gave no other details.Police uncovered the scam through advertisements the group placed on the Internet, the reports said. In May 2006, they arrested 10 people, including Wang, and confiscated more than 2,600 capsules of the bogus drug in raids on two workshops, the reports said.
Pharmacists who purchased the drug told police they had doubts about its origin, but bought it anyway because it was much cheaper than the genuine product produced by Swiss pharmaceutical maker Roche Holding AG and its licensees.
The case is typical of the wide-scale violation of intellectual property rights across almost all industries in China, as well as deep problems with medical integrity in the country's troubled health system.
In another trial involving a high-profile drug, Viagra maker Pfizer Inc. recently appealed a Chinese court ruling that lets a rival use one of the Chinese-language names for its popular anti-impotence drug.
Tamiflu is seen as perhaps the best initial defense if the H5N1 strain of bird flu, which has killed at least 163 people worldwide and prompted the slaughter of millions of birds across Asia since late 2003, mutates into a form spread easily among humans.
Sales of Tamiflu, which governments around the world have been stockpiling to prepare for a possible influenza pandemic, soared 68 percent last year to $2.11 billion, largely on government orders, according to Roche.
